Cepheid (Nasdaq: CPHD) announced the release of Xpert Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE